Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy P Cripe

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Sarcoma|December 15, 2010
Ewing sarcoma: an eponym window to historyTimothy P Cripe
Paediatric Drugs|November 25, 2021
Immunotherapies for Pediatric Solid Tumors: A Targeted UpdateAjay Gupta, Timothy P Cripe
Pediatric Clinics of North America|February 13, 2003
Emerging cancer-targeted therapiesRobert J Arceci, Timothy P Cripe
Advances in Experimental Medicine and Biology|August 9, 2020
Oncolytic Viruses and Their Potential as a Therapeutic Opportunity in OsteosarcomaMary Frances Wedekind, Timothy P Cripe
Journal of Pediatric Hematology/Oncology|September 16, 2003
Effect of combined cyclooxygenase-2 and matrix metalloproteinase inhibition on human sarcoma xenograftsDavid S Dickens, Timothy P Cripe
Therapeutic Innovation & Regulatory Science|May 2, 2018
Unique Burdens of Pediatric Clinical Trials in Duchenne Muscular Dystrophy, April 20-21, 2017, Bethesda, Maryland, USATimothy Franson, Kathi Kinnett, Timothy P Cripe
Current Pharmaceutical Biotechnology|July 12, 2011
Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progressBalveen Kaur, E Antonio Chiocca, Timothy P Cripe
Current Gene Therapy|October 29, 2009
"Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironmentBalveen Kaur, Timothy P Cripe, E Antonio Chiocca
Molecular Therapy Oncolytics|September 8, 2023
The quest for effective immunotherapies against malignant peripheral nerve sheath tumors: Is there hope?Siddhi N Paudel, Brian Hutzen, Timothy P Cripe
Pediatric Blood & Cancer|August 25, 2010
Oncolytic virotherapy reaches adolescenceAdrienne M Hammill, Joseph Conner, Timothy P Cripe
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Sarcoma|December 15, 2010
Ewing sarcoma: an eponym window to historyTimothy P Cripe
Paediatric Drugs|November 25, 2021
Immunotherapies for Pediatric Solid Tumors: A Targeted UpdateAjay Gupta, Timothy P Cripe
Pediatric Clinics of North America|February 13, 2003
Emerging cancer-targeted therapiesRobert J Arceci, Timothy P Cripe
Advances in Experimental Medicine and Biology|August 9, 2020
Oncolytic Viruses and Their Potential as a Therapeutic Opportunity in OsteosarcomaMary Frances Wedekind, Timothy P Cripe
Journal of Pediatric Hematology/Oncology|September 16, 2003
Effect of combined cyclooxygenase-2 and matrix metalloproteinase inhibition on human sarcoma xenograftsDavid S Dickens, Timothy P Cripe
Therapeutic Innovation & Regulatory Science|May 2, 2018
Unique Burdens of Pediatric Clinical Trials in Duchenne Muscular Dystrophy, April 20-21, 2017, Bethesda, Maryland, USATimothy Franson, Kathi Kinnett, Timothy P Cripe
Current Pharmaceutical Biotechnology|July 12, 2011
Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progressBalveen Kaur, E Antonio Chiocca, Timothy P Cripe
Current Gene Therapy|October 29, 2009
"Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironmentBalveen Kaur, Timothy P Cripe, E Antonio Chiocca
Molecular Therapy Oncolytics|September 8, 2023
The quest for effective immunotherapies against malignant peripheral nerve sheath tumors: Is there hope?Siddhi N Paudel, Brian Hutzen, Timothy P Cripe
Pediatric Blood & Cancer|August 25, 2010
Oncolytic virotherapy reaches adolescenceAdrienne M Hammill, Joseph Conner, Timothy P Cripe
Pageof 13